ASCO® 2024 Summary: "Gynecologic Oncology Updates"

2024 ASCO® Annual Meeting Insights Hub

R. Salani

ASCO® 2024 Insights: "The ABCs of ADCs - What Does the Future Hold?"

2024 ASCO® Annual Meeting Insights Hub

E. Hamilton

ESMO 2024 Insights: Final OS With Niraparib as 1L Maintenance in Adv…

2024 ESMO Annual Meeting Insights Hub

B. Monk

ASCO® 2024 Summary: "Gynecological Cancers Highlights"

2024 ASCO® Annual Meeting Insights Hub

M. Raza Mirza

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

Oncologists' Perspectives on the Effects of Time Toxicity in Cancer …

Safiya Karim

ESMO 2024 Summary: The Emerging Global Epidemic of Early-Onset Cance…

2024 ESMO Annual Meeting Insights Hub

S. Ogino

Gynecologic Oncology Updates: Expert Perspective on Key Trial Findin…

Yale Cancer Center

E. Ratner

ESMO 2024 Summary: Advances in Cervical Cancer Management - Comprehe…

2024 ESMO Annual Meeting Insights Hub

D. Lorusso

ESMO 2024 Insights: Rucaparib +/- Nivo as Maintenance in Newly Diagn…

2024 ESMO Annual Meeting Insights Hub

B. Monk

ASCO® 2024 Summary: "Timing of Debulking Surgery in Advanced Endomet…

2024 ASCO® Annual Meeting Insights Hub

A. Karam

Updates in the Management of Cervical Cancer

Abdulrahman Sinno

Chemotherapy-Induced Hair Loss: Insights and Effective Strategies

Masonic Cancer Center, University of Minnesota

M. Hordinsky

ESMO 2024 Insights: OS Results for Pembro + CRT for High-Risk Locall…

2024 ESMO Annual Meeting Insights Hub

D. Lorusso

Year in Review 2024 - Ovarian Cancer

Oncology 2024 Year in Review

E. Crane

ESMO 2024 Insights: PRIMA Trial - Newly Diagnosed Advanced Ovarian C…

ecancer

A. González-Martín

ESMO 2024 Insights: Mirvetuximab Soravtansine-gynx (MIRV) in Platinu…

2024 ESMO Annual Meeting Insights Hub

A. Secord

Cancer Screening Molecular Tools

Fengting Yan

Induction CT Followed by Standard CRT vs. CRT Alone in Locally Advan…

Gemma Eminowicz

Management of Recurrent Ovarian Clear Cell Carcinoma

David Tan